

HY-114491A · Free Sample (0.1 - 0.2 mg)
MedChemExpress · Cat: HY-114491A
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/rineterkib-hydrochloride.html
Description
Rineterkib hydrochloride compound B is an orally available ERK1 and ERK2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer CRC and KRAS-mutant ovarian cancer. Rineterkib hydrochloride can also inhibit RAF.







